125742 S2 M3 32p52 analytical procedure subvis particulate matter
Document text
BNT162b2 3.2.P.5.2 Analytical Procedures Subvisible Particulate Matter PFIZER CONFIDENTIAL Page 13.2.P.5.2. SUBVISIBLE PARTICULATE MATTER The anal ytical procedure for measuring subvisible particulate matter in BNT162b2 drug product is performed using the test in accordance with USP <787>and Ph. Eur. 2.9.19. 090177e19700aef1\Approved\Approved On: 12-May-2021 07:26 (GMT) (b) (4) FDA-CBER-2021-5683-1149278